Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Kiora Pharmaceuticals Inc. (KPRX)

Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kiora Pharmaceuticals Inc. 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 USA

www.kiorapharma.com Employees: 12 P: 858-224-9600

Description:

Kiora Pharmaceuticals Inc. is a clinical-stage specialty pharmaceutical company. It involved in developing and commercializing products for treating ophthalmic diseases. The company's product pipeline includes KIO-301, KIO-101 and KIO-201. Kiora Pharmaceuticals Inc., formerly known as EyeGate Pharmaceuticals Inc., is based in SALT LAKE CITY.

Key Statistics

Overview:

Market Capitalization, $K 10,110
Enterprise Value, $K 7,660
Shares Outstanding, K 3,001
Annual Sales, $ 0 K
Annual Net Income, $ -12,510 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -2,220 K
EBIT, $ 2,640 K
EBITDA, $ 2,690 K
60-Month Beta -0.29
% of Insider Shareholders 0.94%
% of Institutional Shareholders 76.97%
Float, K 2,973
% Float 99.06%
Short Volume Ratio 0.43

Growth:

1-Year Return -32.93%
3-Year Return -99.26%
5-Year Return -99.87%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 98.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.81 on 11/08/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -5.12
EPS Growth vs. Prev Qtr -52.83%
EPS Growth vs. Prev Year 89.89%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-9 on 06/11/24

KPRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 3.72
Price/Earnings to Growth N/A
Return-on-Equity % 21.32%
Return-on-Assets % 16.39%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 0.68
Price/Cash Flow N/A
Price/Book 0.33
Book Value/Share 11.34
Interest Coverage -1,241.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar